These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 24215293

  • 1. Anti-VEGF therapy (bevacizumab) for sulfur mustard-induced corneal neovascularization associated with delayed limbal stem cell deficiency in rabbits.
    Kadar T, Amir A, Cohen L, Cohen M, Sahar R, Gutman H, Horwitz V, Dachir S.
    Curr Eye Res; 2014 May; 39(5):439-50. PubMed ID: 24215293
    [Abstract] [Full Text] [Related]

  • 2. Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.
    Kadar T, Dachir S, Cohen L, Sahar R, Fishbine E, Cohen M, Turetz J, Gutman H, Buch H, Brandeis R, Horwitz V, Solomon A, Amir A.
    Toxicology; 2009 Sep 01; 263(1):59-69. PubMed ID: 19061933
    [Abstract] [Full Text] [Related]

  • 3. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
    Gore A, Horwitz V, Cohen M, Gutman H, Cohen L, Gez R, Kadar T, Dachir S.
    Exp Eye Res; 2018 Jun 01; 171():183-191. PubMed ID: 29548928
    [Abstract] [Full Text] [Related]

  • 4. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR.
    Invest Ophthalmol Vis Sci; 2009 Apr 01; 50(4):1659-65. PubMed ID: 18997093
    [Abstract] [Full Text] [Related]

  • 5. The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency.
    Lin CT, Hu FR, Kuo KT, Chen YM, Chu HS, Lin YH, Chen WL.
    Invest Ophthalmol Vis Sci; 2010 Dec 01; 51(12):6277-85. PubMed ID: 20435600
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI, Kim SW, Kim S, Kim T, Kim EK.
    Cornea; 2008 Apr 01; 27(3):349-52. PubMed ID: 18362666
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.
    Chen WL, Chen YM, Chu HS, Lin CT, Chow LP, Chen CT, Hu FR.
    PLoS One; 2014 Apr 01; 9(4):e94205. PubMed ID: 24714670
    [Abstract] [Full Text] [Related]

  • 8. Delayed loss of corneal epithelial stem cells in a chemical injury model associated with limbal stem cell deficiency in rabbits.
    Kadar T, Horwitz V, Sahar R, Cohen M, Cohen L, Gez R, Tveria L, Gutman H, Buch H, Fishbine E, Brandeis R, Dachir S, Amir A.
    Curr Eye Res; 2011 Dec 01; 36(12):1098-107. PubMed ID: 21988526
    [Abstract] [Full Text] [Related]

  • 9. Limbal stem cell deficiency (LSCD) in rats and mice following whole body exposure to sulfur mustard (SM) vapor.
    Kadar T, Horwitz V, Cohen M, Egoz I, Gutman H, Gez R, Dachir S.
    Exp Eye Res; 2022 Oct 01; 223():109195. PubMed ID: 35917998
    [Abstract] [Full Text] [Related]

  • 10. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
    Su W, Li Z, Li Y, Lin M, Yao L, Liu Y, He Z, Wu C, Liang D.
    Invest Ophthalmol Vis Sci; 2011 Nov 25; 52(12):9108-15. PubMed ID: 22039247
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
    Ko BY, Kim YS, Baek SG, Lee GW, Kim JM, Jean WS, Lee NS, Kang J.
    Cornea; 2013 May 25; 32(5):689-95. PubMed ID: 23377751
    [Abstract] [Full Text] [Related]

  • 12. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model.
    Mirabelli P, Peebo BB, Xeroudaki M, Koulikovska M, Lagali N.
    Exp Eye Res; 2014 Aug 25; 125():118-27. PubMed ID: 24933712
    [Abstract] [Full Text] [Related]

  • 13. Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization.
    Agarwal S, Angayarkanni N, Iyer G, Srinivasan B, Natarajan R, Charola S, Arumugam S, Padmanabhan P.
    Cornea; 2014 Oct 25; 33(10):1016-21. PubMed ID: 25090164
    [Abstract] [Full Text] [Related]

  • 14. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
    Lee HS, Chung SK.
    Cornea; 2010 Jan 25; 29(1):86-92. PubMed ID: 19907290
    [Abstract] [Full Text] [Related]

  • 15. The effect of bevacizumab on corneal neovascularization in rabbits.
    Kim WJ, Jeong HO, Chung SK.
    Korean J Ophthalmol; 2010 Aug 25; 24(4):230-6. PubMed ID: 20714387
    [Abstract] [Full Text] [Related]

  • 16. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
    Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P, Tübingen Bevacizumab Study Group.
    Acta Ophthalmol; 2008 May 25; 86(3):322-8. PubMed ID: 17995975
    [Abstract] [Full Text] [Related]

  • 17. Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits.
    Yoo AR, Chung SK.
    Cornea; 2014 Oct 25; 33(10):1088-94. PubMed ID: 25119962
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z.
    Invest Ophthalmol Vis Sci; 2005 Nov 25; 46(11):4062-71. PubMed ID: 16249481
    [Abstract] [Full Text] [Related]

  • 19. Prolonged impairment of corneal innervation after exposure to sulfur mustard and its relation to the development of delayed limbal stem cell deficiency.
    Kadar T, Dachir S, Cohen M, Gutman H, Cohen L, Brandeis R, Horwitz V, Amir A.
    Cornea; 2013 Apr 25; 32(4):e44-50. PubMed ID: 23132440
    [Abstract] [Full Text] [Related]

  • 20. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
    Avisar I, Weinberger D, Kremer I.
    Curr Eye Res; 2010 Feb 25; 35(2):108-15. PubMed ID: 20136420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.